ARGX

Q: What is the price of argenx (ARGX) today?

The current price of argenx (ARGX) is $846.19. The stock began the year trading around $840.95 and is currently priced at $846.19. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

Q: When does argenx (ARGX) pay dividends?

argenx (ARGX) did not pay dividends over the past year.

Q: Is argenx (ARGX) a good investment?

argenx (ARGX) is currently trading at $846.19 with a P/E ratio of 6.64. This represents a -3,110% premium compared to its historical average P/E. Over the past year, the stock paid $0.00 in dividends, resulting in a dividend yield of 0.00%. The total shareholder return over the same period was 49.88%.Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

argenx SE

Price

$846.19

return (12m)

49.88%

p/e

6.64

p/bv

1.32

DIVIDEND YIELD

0.00%

ARGX price

argenx

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment ARGX

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-3.59%

3 months

5.07%

1 year

49.88%

2 years

83.55%

5 years

167.29%

10 years

0.00%

Fundamentals ARGX

review the fundamentals of argenx shares

P/E

6.64

Sector: -4.14 Industry: -4.14

P/Revenue (PSR)

2.95

Sector: -4.16 Industry: -4.16

P/BV

1.32

Sector: 2.06 Industry: 2.06

Dividend Yield (DY)

0.00%

Sector: - Industry: -

Payout

0.00%

Sector: - Industry: -

Net Profit Margins

44.36%

Sector: -39.83% Industry: -39.83%

Gross Margin

90.44%

Sector: 36.35% Industry: 36.35%

Operating Margin

29.78%

Sector: -38.68% Industry: -38.68%

EBIT Margin

0.00%

Sector: - Industry: -

EBITDA Margin

0.00%

Sector: - Industry: -

EV/EBITDA

5,253,495,595.84

Sector: - Industry: -

EV/EBIT

Sector: - Industry: -

P/EBITDA

13.27

Sector: -4.29 Industry: -4.29

P/EBIT

13.33

Sector: -4.34 Industry: -4.34

P/Total Assets

1.11

Sector: 1.46 Industry: 1.46

P/Working Capital

Sector: - Industry: -

P/Net Current Assets

Sector: - Industry: -

BVPS

650.05

Sector: 1.92 Industry: 1.92

EPS

129.20

Sector: -2.20 Industry: -2.20

Asset Turnover

0.15

Sector: - Industry: -

ROE

19.88%

Sector: -66.76% Industry: -66.76%

ROIC

Sector: -2,909.64% Industry: -2,909.64%

ROA

16.76%

Sector: -66.63% Industry: -66.63%

Net Debt / Equity

-0.61

Sector: - Industry: -

Net Debt / EBITDA

-4,459,867,449.45

Sector: - Industry: -

Net Debt / EBIT

Sector: - Industry: -

Gross Debt / Equity

0.00

Sector: - Industry: -

Equity / Assets

0.84

Sector: 0.42 Industry: 0.42

Liabilities / Assets

0.16

Sector: 0.39 Industry: 0.39

Current Ratio

Sector: - Industry: -

CAGR Revenue 5 Years

91.40%

Sector: - Industry: -

CAGR Profit 5 Years

0.00%

Sector: - Industry: -

FAIR VALUE OF argenx ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$846.19

Fair Value

$1,374.66

Upside Return potential.

62.45%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals ARGX

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
ARGX	6.64	1.32	19.88%	0.00%	$56.82 B	44.36%
JNJ	28.83	0.00	-%	2.08%	$606.58 B	21.48%
PFE	18.76	1.55	8.29%	6.97%	$140.54 B	11.83%
ABBV	125.53	-69.01	-54.98%	2.61%	$456.30 B	5.79%
NVO	11.83	7.14	60.40%	3.68%	$224.33 B	37.15%
MRK	35.53	6.91	19.45%	2.62%	$317.48 B	13.59%
AZN	25.20	5.52	21.93%	1.89%	$261.78 B	17.19%
GILD	18.39	7.23	39.33%	2.36%	$169.47 B	30.99%
BMY	17.03	6.16	36.19%	4.11%	$123.88 B	15.01%
ZTS	12.10	9.90	81.75%	2.72%	$31.99 B	27.79%
REGN	15.93	2.24	14.08%	0.54%	$70.47 B	29.65%
HALO	26.33	41.81	158.82%	0.00%	$9.18 B	23.13%
AMGN	25.48	21.63	84.87%	2.66%	$198.75 B	20.96%
MCK	21.66	-123.68	-570.98%	0.39%	$103.15 B	1.18%
VRTX	28.35	6.35	22.41%	0.00%	$122.99 B	35.51%
CAH	34.90	-20.31	-58.20%	0.89%	$54.27 B	0.62%
HRMY	13.36	2.14	16.00%	0.00%	$1.95 B	16.20%
BIIB	22.13	1.63	7.36%	0.00%	$30.36 B	13.81%
MEDP	32.62	25.10	76.95%	0.00%	$15.02 B	17.19%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

ARGX Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT argenx

argenx SE

Average Investor10 user rating

4.0 (15 people)

United States

18 years

Founded: 2008

2017

Time since IPO - 9 years

336

Employees

argenx SE (United States) is listed on the Nasdaq and has a market capitalization of $56.82 billion, with shareholders equity totaling $43.03 billion.

The company employs approximately 336 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, argenx SE reported $19.28 billion in revenue, generating net income of $8.55 billion.

Key financial metrics include a P/E ratio of 6.64, a price-to-book (P/B) ratio of 1.32, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker ARGX.

Market cap

$56.82 billion

Net worth

$43.03 billion

$43,031,404,665.00

Assets

$51.02 billion

$51,020,619,599.21

Total Shares Outstanding

66.20 million

66,197,000

Average Daily Trading Volume

$1.94 million

$1,938,610.04

Sector

Health Care

Industry

Biotechnology

ARGX

ARGX revenue and profits

Financial Results ARGX

DRAG THE FRAME TO SEE MORE DATA

ARGX cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$831.46 17,38% (12M)

P/E

21.66

0.39%

ROE

-570.98%

P/BV

-123.68

CAH - Cardinal Health

$225.75 43,85% (12M)

P/E

34.90

0.89%

ROE

-58.20%

P/BV

-20.31

JNJ - Johnson & Johnson

$248.82 56,01% (12M)

P/E

28.83

2.08%

ROE

P/BV

0.00

MRK - Merck & Co.

$124.40 62,05% (12M)

P/E

35.53

2.62%

ROE

19.45%

P/BV

6.91

AZN - AstraZeneca

$164.52 18,76% (12M)

P/E

25.20

1.89%

ROE

21.93%

P/BV

5.52

ABBV - AbbVie

$253.38 42,66% (12M)

P/E

125.53

2.61%

ROE

-54.98%

P/BV

-69.01

NVO - Novo Nordisk

$49.61 --22,12% (12M)

P/E

11.83

3.68%

ROE

60.40%

P/BV

7.14

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$831.46 17,38% (12 M)

P/L

21.66

0.39%

ROE

-570.98%

P/VP

-123.68

CAH - Cardinal Health

$225.75 43,85% (12 M)

P/L

34.90

0.89%

ROE

-58.20%

P/VP

-20.31

JNJ - Johnson & Johnson

$248.82 56,01% (12 M)

P/L

28.83

2.08%

ROE

P/VP

0.00

MRK - Merck & Co.

$124.40 62,05% (12 M)

P/L

35.53

2.62%

ROE

19.45%

P/VP

6.91

AZN - AstraZeneca

$164.52 18,76% (12 M)

P/L

25.20

1.89%

ROE

21.93%

P/VP

5.52

ABBV - AbbVie

$253.38 42,66% (12 M)

P/L

125.53

2.61%

ROE

-54.98%

P/VP

-69.01

NVO - Novo Nordisk

$49.61 --22,12% (12 M)

P/L

11.83

3.68%

ROE

60.40%

P/VP

7.14

Frequently Asked Questions

What is the price of argenx (ARGX) today?

The current price of argenx (ARGX) is $846.19. The stock began the year trading around $840.95 and is currently priced at $846.19. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

When does argenx (ARGX) pay dividends?

argenx (ARGX) did not pay dividends over the past year.

Is argenx (ARGX) a good investment?

argenx (ARGX) is currently trading at $846.19 with a P/E ratio of 6.64. This represents a -3,110% premium compared to its historical average P/E. Over the past year, the stock paid $0.00 in dividends, resulting in a dividend yield of 0.00%. The total shareholder return over the same period was 49.88%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy argenx (ARGX) stock?

You can buy argenx (ARGX) shares through any brokerage account that provides access to U.S. stock exchanges. After opening and funding your account, simply search for the ticker symbol ARGX and place a buy order. Before investing, consider factors such as your financial goals, risk tolerance, and overall portfolio allocation.

How much would 100 shares of argenx (ARGX) yield today?

Over the past month, argenx (ARGX) has returned -3.59% — 49.88% over the past year, and 167.29% over the past five years, including price appreciation and dividends.

In the last 12 months, the company paid a total of 0.00 per share in dividends, resulting in a dividend yield of 0.00%.

If you were to purchase 100 shares of argenx (ARGX) today at the current price of $846.19 your total investment would be $84,619.00.

Based on historical performance, the investment would have grown to approximately:

$126,826.96 after 1 year
$226,178.13 after 5 years
$84,619.00 after 10 years

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

ARGX

argenx SE

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment ARGX

review the fundamentals of argenx shares

P/E

P/Revenue (PSR)

P/BV

Dividend Yield (DY)

Payout

Net Profit Margins

Gross Margin

Operating Margin

EBIT Margin

EBITDA Margin

EV/EBITDA

EV/EBIT

P/EBITDA

P/EBIT

P/Total Assets

P/Working Capital

P/Net Current Assets

BVPS

EPS

Asset Turnover

ROE

ROIC

ROA

Net Debt / Equity

Net Debt / EBITDA

Net Debt / EBIT

Gross Debt / Equity

Equity / Assets

Liabilities / Assets

Current Ratio

CAGR Revenue 5 Years

CAGR Profit 5 Years

Graham's Fair Value

current DY: 0.00%

5-year average DY: 0.00%

ABOUT argenx

argenx SE

United States

18 years

2017

336

PROFIT X PRICE ARGX

Financial Results ARGX

ARGX cash flow

Asset, Revenue and Profit Growth - ARGX

ARGX balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

AZN - AstraZeneca

ABBV - AbbVie

NVO - Novo Nordisk

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

AZN - AstraZeneca

ABBV - AbbVie

NVO - Novo Nordisk

Frequently Asked Questions